{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:10:49Z","timestamp":1784675449124,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,5,9]],"date-time":"2016-05-09T00:00:00Z","timestamp":1462752000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"863 Plan Biological and Medical Technology project, China","award":["2015AA020511"],"award-info":[{"award-number":["2015AA020511"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s00415-016-8155-7","type":"journal-article","created":{"date-parts":[[2016,5,9]],"date-time":"2016-05-09T05:11:54Z","timestamp":1462770714000},"page":"1382-1389","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Optic neuritis: a 5-year follow-up study of Chinese patients based on aquaporin-4 antibody status and ages"],"prefix":"10.1007","volume":"263","author":[{"given":"Huanfen","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quangang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahe","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,9]]},"reference":[{"key":"8155_CR1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","volume":"13","author":"AT Toosy","year":"2014","unstructured":"Toosy AT, Mason DF, Miller DH (2014) Optic neuritis. Lancet Neurol 13:83\u201399","journal-title":"Lancet Neurol"},{"key":"8155_CR2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177\u2013189","journal-title":"Neurology"},{"key":"8155_CR3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jns.2010.07.011","volume":"298","author":"S Jarius","year":"2010","unstructured":"Jarius S, Frederikson J, Waters P, Paul F, Akman-Demir G, Marignier R et al (2010) Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis. J Neurol Sci 298:158\u2013162","journal-title":"J Neurol Sci"},{"issue":"1079\u201382","key":"8155_CR4","first-page":"e5","volume":"115","author":"Optic Neuritis Study G","year":"2008","unstructured":"Optic Neuritis Study G (2008) Visual function 15\u00a0years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial. Ophthalmology 115(1079\u201382):e5","journal-title":"Ophthalmology"},{"key":"8155_CR5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0021-5155(98)00072-0","volume":"43","author":"M Wakakura","year":"1999","unstructured":"Wakakura M, Minei-Higa R, Oono S, Matsui Y, Tabuchi A, Kani K et al (1999) Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG). Jpn J Ophthalmol 43:127\u2013132","journal-title":"Jpn J Ophthalmol"},{"key":"8155_CR6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/jnnp.2008.146894","volume":"81","author":"A Petzold","year":"2010","unstructured":"Petzold A, Pittock S, Lennon V, Maggiore C, Weinshenker BG, Plant GT (2010) Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis. J Neurol Neurosurg Psychiatry 81:109\u2013111","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8155_CR7","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/archopht.1991.01080120052024","volume":"109","author":"JF Rizzo 3rd","year":"1991","unstructured":"Rizzo JF 3rd, Lessell S (1991) Optic neuritis and ischemic optic neuropathy: overlapping clinical profiles. Arch Ophthalmol 109:1668\u20131672","journal-title":"Arch Ophthalmol"},{"key":"8155_CR8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1212\/WNL.45.2.244","volume":"45","author":"M Rodriguez","year":"1995","unstructured":"Rodriguez M, Siva A, Cross SA, O\u2019Brien PC, Kurland LT (1995) Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology 45:244\u2013250","journal-title":"Neurology"},{"key":"8155_CR9","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.autrev.2014.01.012","volume":"13","author":"R Milo","year":"2014","unstructured":"Milo R, Miller A (2014) Revised diagnostic criteria of multiple sclerosis. Autoimmun Rev 13:518\u2013524","journal-title":"Autoimmun Rev"},{"key":"8155_CR10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177\u2013189","journal-title":"Neurology"},{"key":"8155_CR11","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.ophtha.2015.03.022","volume":"122","author":"Y Tang","year":"2015","unstructured":"Tang Y, Wang X, Wang J, Huang W, Gao Y, Luo Y et al (2015) Prevalence and causes of visual impairment in a chinese adult population: the Taizhou Eye Study. Ophthalmology 122:1480\u20131488","journal-title":"Ophthalmology"},{"key":"8155_CR12","first-page":"94","volume":"20","author":"Y Yang","year":"2013","unstructured":"Yang Y, Huang DH, Wu WP, Wu L, Chen LF, Wu Q (2013) The role of aquaporin-4 antibodies in Chinese patients with neuromyelitis optica. J Clin Neurosci Off J Neurosurg Soc Australas 20:94\u201398","journal-title":"J Clin Neurosci Off J Neurosurg Soc Australas"},{"key":"8155_CR13","first-page":"727","volume":"65","author":"Optic Neuritis Study G","year":"2008","unstructured":"Optic Neuritis Study G (2008) Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol 65:727\u2013732","journal-title":"Arch Neurol"},{"key":"8155_CR14","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000303817.82134.da","volume":"70","author":"M Matiello","year":"2008","unstructured":"Matiello M, Lennon VA, Jacob A, Pittock SJ, Lucchinetti CF, Wingerchuk DM et al (2008) NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 70:2197\u20132200","journal-title":"Neurology"},{"key":"8155_CR15","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s10792-015-0048-8","volume":"35","author":"S Ambika","year":"2015","unstructured":"Ambika S, Balasubramanian M, Theresa L, Veeraputhiran A, Arjundas D (2015) Aquaporin 4 antibody [NMO Ab] status in patients with severe optic neuritis in India. Int Ophthalmol 35:801\u2013806","journal-title":"Int Ophthalmol"},{"key":"8155_CR16","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1755-3768.2008.01259.x","volume":"87","author":"M Takagi","year":"2009","unstructured":"Takagi M, Tanaka K, Suzuki T, Miki A, Nishizawa M, Abe H (2009) Anti-aquaporin-4 antibody-positive optic neuritis. Acta Ophthalmol 87:562\u2013566","journal-title":"Acta Ophthalmol"},{"key":"8155_CR17","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.clineuro.2012.01.022","volume":"114","author":"Y Long","year":"2012","unstructured":"Long Y, Qiu W, Hu X, Peng F, Lu Z, Wang Y et al (2012) Anti-aquaporin-4 antibody in Chinese patients with central nervous system inflammatory demyelinating disorders. Clin Neurol Neurosurg 114:1131\u20131134","journal-title":"Clin Neurol Neurosurg"},{"key":"8155_CR18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/WNO.0b013e3181f8a693","volume":"31","author":"C Lai","year":"2011","unstructured":"Lai C, Tian G, Takahashi T, Liu W, Yang L, Zhang X (2011) Neuromyelitis optica antibodies in patients with severe optic neuritis in China. J Neuroophthalmol Off J North Am Neuroophthalmol Soc 31:16\u201319","journal-title":"J Neuroophthalmol Off J North Am Neuroophthalmol Soc"},{"key":"8155_CR19","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/brain\/aws109","volume":"135","author":"J Kitley","year":"2012","unstructured":"Kitley J, Leite MI, Nakashima I, Waters P, McNeillis B, Brown R et al (2012) Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. Brain J Neurol 135:1834\u20131849","journal-title":"Brain J Neurol"},{"key":"8155_CR20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/nyas.12794","volume":"1366","author":"SJ Pittock","year":"2016","unstructured":"Pittock SJ, Lucchinetti CF (2016) Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later. Ann NY Acad Sci 1366:20\u201339","journal-title":"Ann NY Acad Sci"},{"key":"8155_CR21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/aos.12187","volume":"92","author":"M Siuko","year":"2014","unstructured":"Siuko M, Tienari PJ, Saastamoinen KP, Atula S, Miettinen A, Kivela T et al (2014) Neuromyelitis optica and aquaporin-4 (AQP4) autoantibodies in consecutive optic neuritis patients in Southern Finland. Acta Ophthalmol 92:387\u2013391","journal-title":"Acta Ophthalmol"},{"key":"8155_CR22","doi-asserted-by":"crossref","first-page":"e99323","DOI":"10.1371\/journal.pone.0099323","volume":"9","author":"H Li","year":"2014","unstructured":"Li H, Zhang Y, Yi Z, Huang D, Wei S (2014) Frequency of autoantibodies and connective tissue diseases in Chinese patients with optic neuritis. PLoS One 9:e99323","journal-title":"PLoS One"},{"key":"8155_CR23","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/archneur.61.9.1401","volume":"61","author":"I Pirko","year":"2004","unstructured":"Pirko I, Blauwet LA, Lesnick TG, Weinshenker BG (2004) The natural history of recurrent optic neuritis. Arch Neurol 61:1401\u20131405","journal-title":"Arch Neurol"},{"key":"8155_CR24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jns.2014.12.031","volume":"349","author":"JT Peng","year":"2015","unstructured":"Peng JT, Cong HR, Yan R, Kong XY, Jiang HQ, Wei WB et al (2015) Neurological outcome and predictive factors of idiopathic optic neuritis in China. J Neurol Sci 349:94\u201398","journal-title":"J Neurol Sci"},{"issue":"Pt 9","key":"8155_CR25","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1093\/brain\/122.9.1689","volume":"122","author":"K Yamasaki","year":"1999","unstructured":"Yamasaki K, Horiuchi I, Minohara M, Kawano Y, Ohyagi Y, Yamada T et al (1999) HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain J Neurol 122(Pt 9):1689\u20131696","journal-title":"Brain J Neurol"},{"key":"8155_CR26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jneuroim.2010.11.004","volume":"233","author":"H Wang","year":"2011","unstructured":"Wang H, Dai Y, Qiu W, Zhong X, Wu A, Wang Y et al (2011) HLA-DPB1 0501 is associated with susceptibility to anti-aquaporin-4 antibodies positive neuromyelitis optica in southern Han Chinese. J Neuroimmunol 233:181\u2013184","journal-title":"J Neuroimmunol"},{"key":"8155_CR27","first-page":"496","volume":"50","author":"W Wang","year":"2011","unstructured":"Wang W, Chen YP, Wei DN (2011) The clinical characteristics of early-onset versus late-onset types of myasthenia gravis. Zhonghua nei ke za zhi 50:496\u2013498","journal-title":"Zhonghua nei ke za zhi"},{"key":"8155_CR28","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s00415-012-6478-6","volume":"259","author":"SA Zivkovic","year":"2012","unstructured":"Zivkovic SA, Clemens PR, Lacomis D (2012) Characteristics of late-onset myasthenia gravis. J Neurol 259:2167\u20132171","journal-title":"J Neurol"},{"key":"8155_CR29","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1212\/WNL.0b013e3182a4a49c","volume":"81","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, Iizuka T, Kawachi I, Bataller L et al (2013) Late-onset anti-NMDA receptor encephalitis. Neurology 81:1058\u20131063","journal-title":"Neurology"},{"key":"8155_CR30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3341\/kjo.2012.26.2.111","volume":"26","author":"J Choi","year":"2012","unstructured":"Choi J, Kim SJ, Chang JW, Kim JH, Yu YS (2012) Clinical characteristics of optic neuritis in Koreans greater than 50\u00a0years of age. Korean J Ophthalmol KJO 26:111\u2013115","journal-title":"Korean J Ophthalmol KJO"},{"key":"8155_CR31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrneurol.2013.118","volume":"9","author":"M Reindl","year":"2013","unstructured":"Reindl M, Di Pauli F, Rostasy K, Berger T (2013) The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol 9:455\u2013461","journal-title":"Nat Rev Neurol"},{"key":"8155_CR32","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1212\/NXI.0000000000000040","volume":"1","author":"S Ramanathan","year":"2014","unstructured":"Ramanathan S, Reddel SW, Henderson A, Parratt JD, Barnett M, Gatt PN et al (2014) Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis. Neurology(R) Neuroimmunol Neuroinflamm 1:e40","journal-title":"Neurology(R) Neuroimmunol Neuroinflamm"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8155-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-016-8155-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8155-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T12:16:00Z","timestamp":1567858560000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-016-8155-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,9]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["8155"],"URL":"https:\/\/doi.org\/10.1007\/s00415-016-8155-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,9]]}}}